by Bob Yirka, Medical Xpress C. difficile spore (gold) emerging from a bacterium (turquoise). Credit: Jeshina Janardhanan and Yuanyuan Qian A team of biochemists at the University of Notre Dame has found a possible new way to treat patients infected with Clostridioides difficile, a type of bacteria that causes serious gastrointestinal problems. In their study,...
by Imperial College London Credit: Unsplash/CC0 Public Domain A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year. Antibodies in the nasal fluid (known as immunoglobulin A, or IgA) provide first-line defense against COVID-19 by blocking SARS-CoV-2 virus...
by John Donne Potter, The Conversation Credit: Shutterstock/Elizaveta Galitckaia The latest omicron variant BA.5 is fast becoming dominant worldwide, including in New Zealand and Australia. As it continues to surge, reinfection will become increasingly common and this in turn means more people will develop long COVID. The two most concerning aspects of long COVID are its high...
By Michael Greenwood Throughout the COVID-19 pandemic, there has been much uncertainty about how long immunity lasts after an unvaccinated person is infected with SARS-CoV-2. Now a team of scientists led by faculty at Yale School of Public Health and the University of North Carolina at Charlotte have an answer: Strong protection following natural infection...
by Marilynn Marchione This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases – Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. According to two new studies released on Tuesday, Dec....
